Novo Nordisk's Retatrutide Australia: A Potential Solution for Weight Management?
Australia is anticipating the introduction of Retatrutide, a novel medication from Novo Nordisk. This twin-action drug, targeting both GLP-1 and GIP receptors, demonstrates significant performance in clinical trials, indicating a considerable impact on weight loss. While still pending approval by